Most people arrive at a first cycle with expectations set by transformation photos and forum lore, not by the human evidence. This guide sticks to what controlled studies and clinical experience actually show, gives real numbers where they exist, and is explicit about where the honest answer is "we don't have good data." It is reference information, not medical advice, and nothing here endorses use.
The single most useful thing to understand before anything else: the response to exogenous androgens is dose-dependent and, importantly, so is the harm. The frequently cited randomized trial by Bhasin and colleagues (New England Journal of Medicine, 1996) gave healthy men 600 mg of testosterone enanthate weekly for ten weeks and measured roughly 6 kg of fat-free mass gain versus placebo, with the training-plus-testosterone group gaining the most. That study is the backbone of realistic expectations — meaningful muscle gain is real and measurable, but it is not the double-your-size result marketing implies, and 600 mg weekly is already well above what a cautious first course would use.
Why test-only comes first
The near-universal recommendation from experienced users and harm-reduction sources is that a first cycle should be testosterone and nothing else. The reasoning is straightforward and holds up:
- Testosterone is the compound your body already produces and clears through known pathways, so its effects and side effects are the best characterised of any anabolic agent.
- Running one compound means that if something goes wrong — an adverse mood change, blood-pressure rise, or a lab value drifting — you know exactly what caused it. Stack three drugs and you are guessing.
- Estrogen-related side effects from testosterone are manageable because testosterone aromatises predictably; many other compounds bring problems that are harder to reverse.
The benefit people are chasing — more muscle, faster — does not require a stack on a first attempt. The marginal gain from adding compounds is small relative to the added uncertainty, and a beginner has not yet learned how their own body responds to even one drug.
Realistic gains versus realistic risks
Expect, under good training and nutrition, something in the range of a few kilograms of retained lean mass over a first course, with a portion of early scale weight being water and glycogen that recedes afterward. Strength rises faster than tissue. What the evidence also shows, and what is easy to ignore:
- Testosterone reliably lowers HDL cholesterol and can raise haematocrit; supraphysiologic doses push blood pressure up.
- Exogenous testosterone suppresses the hypothalamic-pituitary-gonadal axis, shrinking natural production and testicular size for the duration and often beyond.
- Acne, oily skin, and accelerated male-pattern hair loss in the genetically predisposed are common and dose-related.
Dose ranges people actually use
Common beginner protocols centre on 300-500 mg of testosterone enanthate or testosterone cypionate per week. Some cautious first-timers deliberately start lower, around 200-300 mg weekly, precisely to observe their own response before committing to more. For reference, testosterone replacement therapy typically targets far lower weekly amounts (on the order of 100-150 mg), so even a "low" cycle dose is well into supraphysiologic territory. Higher is not better for a beginner; it mostly buys more side effects for a diminishing gain.
Cycle length and esters
Enanthate and cypionate are long esters with half-lives of roughly 4.5 to 8 days, which is why they are dosed once or twice weekly and why blood levels take several weeks to stabilise. A conventional beginner course runs 12-16 weeks. Shorter than about 10 weeks with a long ester barely reaches steady state before you would stop; much longer prolongs suppression and cumulative strain with little added benefit for a first attempt.
Ancillaries: only what you need
An aromatase inhibitor such as anastrozole is sometimes kept on hand for estrogenic side effects (gynecomastia, water retention), but the modern, evidence-aware view is to use it reactively and at the lowest effective dose — crashing estradiol causes its own harm to libido, joints, mood, and lipids. Tamoxifen is a SERM used both for gynecomastia and as a cornerstone of post-cycle therapy. Neither should be run pre-emptively at high doses "just in case."
Suppression and the PCT reality
Every androgen cycle suppresses your own testosterone. After stopping, recovery is not guaranteed to be quick or complete. Post-cycle therapy — commonly a SERM such as tamoxifen, sometimes with hCG — aims to restart the axis, but the human evidence for standardised PCT protocols in recreational users is thin, and some men experience prolonged low testosterone regardless. This is the risk that gets minimised most often and deserves the most weight.
Health monitoring
Baseline and periodic bloodwork is the one genuinely protective habit. A sensible panel includes a lipid profile, full blood count (for haematocrit), liver markers, and total and free testosterone plus estradiol. Blood pressure should be checked regularly at home, not once a year. These are the measurements that turn an invisible problem into an actionable one.
Bottom line
If someone is going to run a first cycle regardless, the evidence supports the least complicated version: testosterone only, a moderate dose, a defined length, ancillaries used reactively, real bloodwork, and a genuine PCT plan — with clear-eyed acceptance that suppression may not fully reverse. More compounds, higher doses, and pre-emptive drug stacking add risk faster than they add muscle.